Viewing Study NCT03716713


Ignite Creation Date: 2025-12-18 @ 9:44 AM
Ignite Modification Date: 2025-12-18 @ 9:44 AM
Study NCT ID: NCT03716713
Status: None
Last Update Posted: 2019-08-20 00:00:00
First Post: 2018-10-19 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: CeraShield™ Endotracheal Tube Feasibility Study
Sponsor: None
Organization:

Study Overview

Official Title: CeraShield™ Endotracheal Tube Feasibility Study
Status: None
Status Verified Date: 2019-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Single-arm, feasibility study to evaluate the Ceragenin Coated Endotracheal Tube (the CeraShield ETT) in adults who require intubation and are expected to be mechanically ventilated for ≥ 24 hours.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: